Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02128282
Title Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Senhwa Biosciences, Inc.
Indications

cholangiocarcinoma

Therapies

Cisplatin + Gemcitabine

Cisplatin + Gemcitabine + Silmitasertib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.